Posted in | News

Rhodia and National Blue Star to Form Silicone Alliance and Build a Facility in China

Rhodia’s CEO, Jean-Pierre Clamadieu and President Ren Jian Xin of China National Blue Star Corporation have signed today in Beijing a letter of intent to form a strategic alliance for their respective Silicone activities.

The companies are forming the alliance to become a major supplier of Methylchlorosilane and Core Intermediates Silicone Products in the Asia-Pacific region. The project includes an investment in a new facility in Tianjin (China) using Rhodia technology and a joint commercial organization to sell products in the Asia-Pacific region manufactured by the alliance.

Blue Star will gain access to a best in class Methylchlorosilane technology that Rhodia has developed over the past 30 years. Rhodia will have a share of a very competitive upstream intermediates production unit located in Tianjin.

Following the completion of a feasibility study, the partners intend to launch, by early 2005, the construction of a 200 KT Methylchlorosilane facility in the municipality of Tianjin, with a start up capacity in the first quarter of 2007 of 100 KT.

This alliance is a key opportunity for the two companies to enhance their competitiveness and become a major player in the fast growing Asia-Pacific silicone market. Both companies intend to accelerate their respective downstream investments to take full advantage of the strong upstream integration.

This is the first step towards a global alliance in silicones between Rhodia and China National Blue Star Corporation.

For more information on silicones, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.